Research & Studies: CBD for Liver Disease
Here is a list of research and studies on CBD and it’s potential use for treating Liver Disease.
CBD for Liver Disease:
- Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.
- The endocannabinoid system and liver diseases.
- Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
- Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
- Potential of Cannabidiol for the Treatment of Viral Hepatitis
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
IMPORTANT: Most of these studies involve cannabinoid molecules, experimental animals, test tubes, and sometimes human cell-lined studies. It’s important to understand that the Endocannabinoid System exists in all mammals including dogs, cats, rabbits, horses, and humans. CBD affects us in the same way that it affects our pets.